The BSU is one of the largest groups of biostatisticians in Europe and has established itself as an internationally acclaimed centre for research in biostatistics and a major centre for training and knowledge transfer.
The critical mass of methodological, applied and computational expertise amongst our scientists has ensured an excellent balance between innovation and dissemination of statistical methods, with impact on genuine public health issues.
Richard Newton, member of Lorenz Wernisch’s group from the BSU’s Statistical Genomics theme, is analysing data on Streptococcus pneumoniae, also called pneumococcus, which is the main cause of pneumonia and meningitis in children and the elderly and a major cause of mortality worldwide. Asymptomatic carriage of the pneumococcus in the nasopharynx facilitates onwards transmission to […]
In smoking cessation trials, it is common to assume that all those who fail to provide outcome data have also failed to give up smoking. This widely used, and advocated, “missing=smoking” assumption sets smoking cessation trials apart from those performed in other areas. This is because elsewhere it is common to assume that data are […]
- Celebrating '100 years in world-leading biostatistics research'
As one of the Medical Research Council's four foundation units, the MRC Biostatistics Unit will […]
- 23rd Bradford Hill Memorial Lecture
Wednesday 4th June 2014 As part of its centenary celebrations the MRC Biostatistics Unit will […]
- Clinical trials: past present and glorious future?
Wednesday 4th June 2014 Clinical trials: past present and glorious future? This meeting to mark […]
- Medical Research Council Conference on Biostatistics
In celebration of the MRC Biostatistics Unit's Centenary year 24th - 26th March 2014 Queens' […]
- MRC Biostatistics Unit exhibit "Don't just be a statistic, be informed" at Cambridge Science Festival
Saturday 15th and Sunday 23rd March 2014 The BSU will participate in the 20th edition […]
- Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.
Wason, J., Marshall, A., Dunn, J., Stein, RC., Stallard, N.
Br. J. Cancer 110(8): 1950-7. (15th April 2014)
- Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial.
Anagnostou, K., et al.
Lancet 383(9925): 1297-304. (12th April 2014)
- Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation.
Kosmoliaptsis, V., et al.
Kidney Int. [Epub ahead of print]. (9th April 2014)
- How to use published complete case results from weight loss studies in a missing data sensitivity analysis.
Cresswell, L., Mander, AP.
Obesity (Silver Spring) 22(4): 996-1001. (5th April 2014)
- A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials.
Bowden, J., Mander, A.
Pharm Stat [Epub ahead of print]. (2nd April 2014)
See more Publications